Swiss National Bank Sells 2,000 Shares of Globus Medical, Inc. (NYSE:GMED)

Swiss National Bank cut its position in Globus Medical, Inc. (NYSE:GMED – Get Rating) by 1.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 186,000 shares of the medical device company’s stock after selling 2,000 shares during the quarter. Swiss National […]

Related Keywords

United States ,Switzerland ,Swiss , ,Exchange Commission ,Disruptive Technology ,Ronald Blue Trust Inc ,Barclays ,Wipfli Financial Advisors ,Covestor Ltd ,Swiss National Bank ,Benjamin Edwards Inc ,Needham Company ,Globus Medical Inc ,Globus Medical ,Get Rating ,National Bank ,Blue Trust ,Financial Advisors ,Innovative Fusion ,Visit Holdingschannel ,Globus Medical Daily ,Nyse Gmed ,Sgmed ,Medical ,37957720 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,